REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Cramer: Workday, Netflix, Amazon Struggle as Momentum Lags
Jim Cramer's Top Stock Picks: CSCO LB REGN AAPL YHOO
Jim Cramer's 'Mad Money' Recap: Here's Where Money Managers Should Put Their Money
Cramer: Not too late to buy Regeneron
REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
UPDATE: Bank Of America Reiterates On Regeneron Pharmaceuticals Following Several Positive Catalysts
Fighting kids' cancer, one voucher at a time
New data fuels doctors' demands to rewrite U.S. heart guidelines
Sanofi touts new drugs but diabetes outlook disappoints
Regeneron & Sanofi Present Positive Data on PCSK9 Drug
Gilead to Buy Knight Therapeutics' Priority Review Voucher
Regeneron Shares Could Reach $450
Sanofi's Bullish Pipeline Forecast Underwhelms Street
Sanofi eyes more than $38 bln from new drugs after CEO exit
The Zacks Analyst Blog Highlights: Geron, Gilead, Regeneron, Celldex Therapeutics and AbbVie
Sanofi, Regeneron eczema drug gets FDA fast-track designation
Sanofi and Regeneron Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis
Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis
The Forbes Healthcare Summit 2014: The Agenda
Regeneron Pharmaceuticals Inc Stock Racks Up Another Win
7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know
Sanofi SA (SNY), Regeneron Pharmaceuticals (REGN) Eczema Drug Gets FDA ...
Agree To Buy Regeneron Pharmaceuticals At $250, Earn 4.8% Using Options
Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences
Stock Update: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Biotech Stocks in Motion - Amgen, Merrimack Pharma, NPS Pharma, BioMarin ...
Regeneron Pharmaceuticals Has A Bright Future Ahead
Regeneron Pharmaceuticals (REGN) Flagged As Today's Pre-Market Laggard
Regeneron Pharmaceuticals (REGN) Stock Declines on Lower Eylea Revenue ...
